Flavonoid-drug interactions: Effects of flavonoids on ABC transporters

Life Sciences

Volumn 78, Issue 18, 2006, Pages 2116-2130

  Morris, Marilyn E ^a   Zhang, Shuzhong ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

ABC proteins; BCRP; Breast cancer resistance protein; Flavonoids; Herbal dietary supplements; MRP; P glycoprotein

Indexed keywords

ABC TRANSPORTER; ALDOSTERONE; ANTHRACYCLINE DERIVATIVE; CHALCONE DERIVATIVE; CYCLOSPORIN; CYTOKINE; DACTINOMYCIN; DEXAMETHASONE; DIGOXIN; DOXORUBICIN; EPIPODOPHYLLOTOXIN DERIVATIVE; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; GLYCOPROTEIN P; HERBACEOUS AGENT; HOE 33342; HYDROCORTISONE; INDINAVIR; ISOFLAVONE DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; QUERCETIN; QUINIDINE; RITONAVIR; SAQUINAVIR; UNINDEXED DRUG; VINCA ALKALOID;

ALTERNATIVE MEDICINE; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DEGENERATIVE DISEASE; DIET THERAPY; DRUG BIOAVAILABILITY; DRUG INHIBITION; DRUG POTENTIATION; DRUG STRUCTURE; DRUG TRANSPORT; HUMAN; NONHUMAN; OSTEOPOROSIS; PROPHYLAXIS; PROTEIN PHOSPHORYLATION;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; DRUG INTERACTIONS; FLAVONOIDS; HUMANS;

GINKGO BILOBA; SILYBUM; VINCA;

EID: 33644914487     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.12.003     Document Type: Conference Paper

References (189)

1. M. Aklilu, H.L. Kindler, R.C. Donehower, S. Mani, and E.E. Vokes Phase II study of flavopiridol in patients with advanced colorectal cancer Annals of Oncology 14 2003 1270 1273
2. J.D. Allen, and A.H. Schinkel Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2) Molecular Cancer Therapeutics 1 2002 427 434
3. J.D. Allen, R.F. Brinkhuis, J. Wijnholds, and A.H. Schinkel The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin Cancer Research 59 1999 4237 4241
4. R. Allikmets, L.M. Schriml, A. Hutchinson, V. Romano-Spica, and M. Dean A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance Cancer Research 58 1998 5337 5339
5. S.V. Ambudkar, I.H. Lelong, J. Zhang, C.O. Cardarelli, M.M. Gottesman, and I. Pastan Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis Proceedings of the National Academy of Sciences of the United States of America 89 1992 8472 8476
6. D.G. Bailey, J.M. Arnold, C. Munoz, and J.D. Spence Grapefruit juice-felodipine interaction: mechanism, predictability, and effect of naringin Clinical Pharmacology and Therapeutics 53 1993 637 642
7. P. Borst, R. Evers, M. Kool, and J. Wijnholds The multidrug resistance protein family Biochimica et Biophysica Acta 1461 1999 347 357
8. P. Borst, R. Evers, M. Kool, and J. Wijnholds A family of drug transporters: the multidrug resistance-associated proteins Journal of the National Cancer Institute 92 2000 1295 1302
9. A. Boumendjel, F. Bois, C. Beney, A.M. Mariotte, G. Conseil, and A. Di Pietro B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance Bioorganic and Medicinal Chemistry Letters 11 2001 75 77
10. A. Boumendjel, A. Di Pietro, C. Dumontet, and D. Barron Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance Medicinal Research Reviews 22 2002 512 529
11. M. Buchler, J. Konig, M. Brom, J. Kartenbeck, H. Spring, T. Horie, and D. Keppler cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats Journal of Biological Chemistry 271 1996 15091 15098
12. P. Buchler, A.S. Gukovskaya, M. Mouria, M.C. Buchler, M.W. Buchler, H. Friess, S.J. Pandol, H.A. Reber, and O.J. Hines Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid Pancreas 26 2003 264 273
13. A.F. Castro, and G.A. Altenberg Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein Biochemical Pharmacology 53 1997 89 93
14. H.S. Chan, G. Haddad, P.S. Thorner, G. DeBoer, Y.P. Lin, N. Ondrusek, H. Yeger, and V. Ling P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma New England Journal of Medicine 325 1991 1608 1614
15. C.J. Chen, J.E. Chin, K. Ueda, D.P. Clark, I. Pastan, M.M. Gottesman, and I.B. Roninson Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell 47 1986 381 389
16. H.Y. Chen, T.S. Wu, S.F. Su, S.C. Kuo, and P.D. Chao Marked decrease of cyclosporin absorption caused by phellamurin in rats Planta Medicine 68 2002 138 141
17. J. Chen, H. Lin, and M. Hu Metabolism of flavonoids via enteric recycling: role of intestinal disposition Journal of Pharmacology and Experimental Therapeutics 304 2003 1228 1235
18. J.S. Choi, H.K. Choi, and S.C. Shin Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats International Journal of Pharmaceutics 275 2004 165 170
19. J.S. Choi, B.W. Jo, and Y.C. Kim Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin European Journal of Pharmaceutics and Biopharmaceutics 57 2004 313 318
20. S.P. Cole, G. Bhardwaj, J.H. Gerlach, J.E. Mackie, C.E. Grant, K.C. Almquist, A.J. Stewart, E.U. Kurz, A.M. Duncan, and R.G. Deeley Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258 1992 1650 1654
21. S.P. Cole, K.E. Sparks, K. Fraser, D.W. Loe, C.E. Grant, G.M. Wilson, and R.G. Deeley Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells Cancer Research 54 1994 5902 5910
22. G. Conseil, H. Baubichon-Cortay, G. Dayan, J.M. Jault, D. Barron, and A. Di Pietro Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein Proceedings of the National Academy of Sciences of the United States of America 95 1998 9831 9836
23. H.C. Cooray, C.G. Blackmore, L. Maskell, and M.A. Barrand Localisation of breast cancer resistance protein in microvessel endothelium of human brain Neuroreport 13 2002 2059 2063
24. H.C. Cooray, T. Janvilisri, H.W. van Veen, S.B. Hladky, and M.A. Barrand Interaction of the breast cancer resistance protein with plant polyphenols Biochemical Biophysical Research Communications 317 2004 269 275
25. C. Cordon-Cardo, J.P. O'Brien, D. Casals, L. Rittman-Grauer, J.L. Biedler, M.R. Melamed, and J.R. Bertino Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proceedings of the National Academy of Sciences of the United States of America 86 1989 695 698
26. J.W. Critchfield, C.J. Welsh, J.M. Phang, and G.C. Yeh Modulation of adriamycin accumulation and efflux by flavonoids in HCT- 15 colon cells. Activation of P-glycoprotein as a putative mechanism Biochemical Pharmacology 48 1994 1437 1445
27. J.M. Croop, M. Raymond, D. Haber, A. Devault, R.J. Arceci, P. Gros, and D.E. Housman The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues Molecular and Cellular Biology 9 1989 1346 1350
28. Y. Cui, J. Konig, J.K. Buchholz, H. Spring, I. Leier, and D. Keppler Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells Molecular Pharmacology 55 1999 929 937
29. W.S. Dalton Is p-glycoprotein a potential target for reversing clinical drug resistance? Current Opinion in Oncology 6 1994 595 600
30. B. Davies, and T. Morris Physiological parameters in laboratory animals and humans Pharmaceutical Research 10 1993 1093 1095
31. D. de Graaf, R.C. Sharma, E.B. Mechetner, R.T. Schimke, and I.B. Roninson P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake Proceedings of the National Academy of Sciences of the United States of America 93 1996 1238 1242
32. L.A. Doyle, W. Yang, L.V. Abruzzo, T. Krogmann, Y. Gao, A.K. Rishi, and D.D. Ross A multidrug resistance transporter from human MCF-7 breast cancer cells Proceedings of the National Academy of Sciences of the United States of America 95 1998 15665 15670
33. J. Drach, A. Gsur, G. Hamilton, S. Zhao, J. Angerler, M. Fiegl, N. Zojer, M. Raderer, I. Haberl, M. Andreeff, and H. Huber Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes Blood 88 1996 1747 1754
34. G.K. Dresser, D.G. Bailey, B.F. Leake, U.I. Schwarz, P.A. Dawson, D.J. Freeman, and R.B. Kim Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine Clinical Pharmacology and Therapeutics 71 2002 11 20
35. M.P. Ducharme, L.H. Warbasse, and D.J. Edwards Disposition of intravenous and oral cyclosporine after administration with grapefruit juice Clinical Pharmacology and Therapeutics 57 1995 485 491
36. J. Duggan, W.S. Peterson, M. Schutz, S. Khuder, and J. Charkraborty Use of complementary and alternative therapies in HIV-infected patients AIDS Patient Care STDs 15 2001 159 167
37. J. Dupuy, G. Larrieu, J.F. Sutra, A. Lespine, and M. Alvinerie Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin Veterinary Parasitology 112 2003 337 347
38. I. Erlund, E. Meririnne, G. Alfthan, and A. Aro Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice Journal of Nutrition 131 2001 235 241
39. R. Evers, G.J. Zaman, L. van Deemter, H. Jansen, J. Calafat, L.C. Oomen, R.P. Oude Elferink, P. Borst, and A.H. Schinkel Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells Journal of Clinical Investigation 97 1996 1211 1218
40. R. Evers, M. de Haas, R. Sparidans, J. Beijnen, P.R. Wielinga, J. Lankelma, and P. Borst Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export British Journal of Cancer 83 2000 375 383
41. I.F. Faneyte, P.M. Kristel, M. Maliepaard, G.L. Scheffer, R.J. Scheper, J.H. Schellens, and M.J. van de Vijver Expression of the breast cancer resistance protein in breast cancer Clinical Cancer Research 8 2002 1068 1074
42. D.R. Ferry, A. Smith, J. Malkhandi, D.W. Fyfe, P.G. deTakats, D. Anderson, J. Baker, and D.J. Kerr Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clinical Cancer Research 2 1996 659 668
43. M. Filipits, R.W. Suchomel, G. Dekan, K. Haider, G. Valdimarsson, D. Depisch, and R. Pirker MRP and MDR1 gene expression in primary breast carcinomas Clinical Cancer Research 2 1996 1231 1237
44. R.E. Friedrich, C. Punke, and A. Reymann Expression of multi-drug resistance genes (mdr1, mrp1, bcrp) in primary oral squamous cell carcinoma In Vivo 18 2004 133 147
45. U. Fuhr, A. Maier-Bruggemann, H. Blume, W. Muck, S. Unger, J. Kuhlmann, C. Huschka, M. Zaigler, S. Rietbrock, and A.H. Staib Grapefruit juice increases oral nimodipine bioavailability International Journal of Clinical Pharmacology and Therapeutics 36 1998 126 132
46. U.A. Germann P-glycoprotein-a mediator of multidrug resistance in tumour cells European Journal of Cancer 32A 1996 927 944
47. M.M. Gottesman, and I. Pastan Biochemistry of multidrug resistance mediated by the multidrug transporter Annual Review of Biochemistry 62 1993 385 427
48. C.E. Grant, G. Valdimarsson, D.R. Hipfner, K.C. Almquist, S.P. Cole, and R.G. Deeley Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs Cancer Research 54 1994 357 361
49. S. Gregorcyk, Y. Kang, D. Brandt, P. Kolm, G. Singer, and R.R. Perry p-Glycoprotein expression as a predictor of breast cancer recurrence Annals of Surgical Oncology 3 1996 8 14
50. P. Gros, M. Raymond, J. Bell, and D. Housman Cloning and characterization of a second member of the mouse mdr gene family Molecular and Cellular Biology 8 1988 2770 2778
51. J.B. Harborne, and C.A. Williams Advances in flavonoid research since 1992 Phytochemistry 55 2000 481 504
52. B.H. Havsteen The biochemistry and medical significance of the flavonoids Pharmacology and Therapeutics 96 2002 67 202
53. M.G. Hertog, E.J. Feskens, P.C. Hollman, M.B. Katan, and D. Kromhout Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study Lancet 342 1993 1007 1011
54. P.C. Hollman, J.H. de Vries, S.D. van Leeuwen, M.J. Mengelers, and M.B. Katan Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers American Journal of Clinical Nutrition 62 1995 1276 1282
55. P.C. Hollman, M. van der Gaag, M.J. Mengelers, J.M. van Trijp, J.H. de Vries, and M.B. Katan Absorption and disposition kinetics of the dietary antioxidant quercetin in man Free Radical Biology and Medicine 21 1996 703 707
56. M. Horio, K.V. Chin, S.J. Currier, S. Goldenberg, C. Williams, I. Pastan, M.M. Gottesman, and J. Handler Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia Journal of Biological Chemistry 264 1989 14880 14884
57. S.L. Hsiu, Y.C. Hou, Y.H. Wang, C.W. Tsao, S.F. Su, and P.D. Chao Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats Life Sciences 72 2002 227 235
58. M. Hu, K. Krausz, J. Chen, X. Ge, J. Li, H.L. Gelboin, and F.J. Gonzalez Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones Drug Metabolism and Disposition 31 2003 924 931
59. R.R. Huxley, and H.A. Neil The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies European Journal of Clinical Nutrition 57 2003 904 908
60. Y. Imai, S. Asada, S. Tsukahara, E. Ishikawa, T. Tsuruo, and Y. Sugimoto Breast cancer resistance protein exports sulfated estrogens but not free estrogens Molecular Pharmacology 64 2003 610 618
61. Y. Imai, S. Tsukahara, S. Asada, and Y. Sugimoto Phytoestrogens/ flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance Cancer Research 64 2004 4346 4352
62. K. Ito, M. Fujimori, S. Nakata, Y. Hama, K. Shingu, S. Kobayashi, S. Tsuchiya, K. Kohno, M. Kuwano, and J. Amano Clinical significance of the increased multidrug resistance-associated protein (MRP) gene expression in patients with primary breast cancer Oncology Research 10 1998 99 109
63. W. Jager, E. Gehring, B. Hagenauer, S. Aust, A. Senderowicz, and T. Thalhammer Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2) Life Sciences 73 2003 2841 2854
64. Y. Ji, and M.E. Morris Effect of organic isothiocyanates on breast cancer resistance protein (ABCG2)-mediated transport Pharmaceutical Research 21 2004 2261 2269
65. J. Jodoin, M. Demeule, and R. Beliveau Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols Biochimica et Biophysica Acta 1542 2002 149 159
66. D.R. Johnson, R.A. Finch, Z.P. Lin, C.J. Zeiss, and A.C. Sartorelli The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice Cancer Research 61 2001 1469 1476
67. J.W. Jonker, M. Buitelaar, E. Wagenaar, M.A. Van Der Valk, G.L. Scheffer, R.J. Scheper, T. Plosch, F. Kuipers, R.P. Elferink, and H. Rosing The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria Proceedings of the National Academy of Sciences of the United States of America 99 2002 15649 15654
68. R.L. Juliano, and V. Ling A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants Biochimica et Biophysica Acta 455 1976 152 162
69. S. Kajihara, A. Hisatomi, T. Mizuta, T. Hara, I. Ozaki, I. Wada, and K. Yamamoto A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome Biochemical and Biophysical Research Communications 253 1998 454 457
70. A. Kanzaki, M. Toi, K. Nakayama, H. Bando, M. Mutoh, T. Uchida, M. Fukumoto, and Y. Takebayashi Expression of multidrug resistance-related transporters in human breast carcinoma Japanese Journal of Cancer Research 92 2001 452 458
71. J. Kartenbeck, U. Leuschner, R. Mayer, and D. Keppler Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome Hepatology 23 1996 1061 1066
72. S. Kawabata, M. Oka, K. Shiozawa, K. Tsukamoto, K. Nakatomi, H. Soda, M. Fukuda, Y. Ikegami, K. Sugahara, and Y. Yamada Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells Biochemical and Biophysical Research Communications 280 2001 1216 1223
73. S.O. Keli, M.G. Hertog, E.J. Feskens, and D. Kromhout Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study Archives of Internal Medicine 156 1996 637 642
74. J.T. Kellis Jr., and L.E. Vickery Inhibition of human estrogen synthetase (aromatase) by flavones Science 225 1984 1032 1034
75. E.H. Koh, H.C. Chung, K.B. Lee, H.Y. Lim, J.H. Kim, J.K. Roh, J.S. Min, K.S. Lee, and B.S. Kim The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy Yonsei Medical Journal 33 1992 137 142
76. H. Kohno, T. Tanaka, K. Kawabata, Y. Hirose, S. Sugie, H. Tsuda, and H. Mori Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats International Journal of Cancer 101 2002 461 468
77. J. Konig, A.T. Nies, Y. Cui, I. Leier, and D. Keppler Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance Biochimica et Biophysica Acta 1461 1999 377 394
78. G.D. Kruh, A. Chan, K. Myers, K. Gaughan, T. Miki, and S.A. Aaronson Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene Cancer Research 54 1994 1649 1652
79. J. Kuhnau The flavonoids. A class of semi-essential food components: their role in human nutrition World Review of Nutrition and Dietetics 24 1976 117 191
80. H.H. Kupferschmidt, K.E. Fattinger, H.R. Ha, F. Follath, and S. Krahenbuhl Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man British Journal of Clinical Pharmacology 45 1998 355 359
81. H. Kusuhara, H. Suzuki, and Y. Sugiyama The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs Journal of Pharmaceutical Sciences 87 1998 1025 1040
82. M.Y. Lai, S.L. Hsiu, Y.C. Hou, S.Y. Tsai, and P.D. Chao Significant decrease of cyclosporine bioavailability in rats caused by a decoction of the roots of Scutellaria baicalensis Planta Medica 70 2004 132 137
83. B. Laupeze, L. Amiot, B. Drenou, M. Bernard, B. Branger, J.M. Grosset, T. Lamy, R. Fauchet, and O. Fardel High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival British Journal of Haematology 116 2002 834 838
84. H.P. Lee, L. Gourley, S.W. Duffy, J. Esteve, J. Lee, and N.E. Day Dietary effects on breast-cancer risk in Singapore Lancet 337 1991 1197 1200
85. M.J. Lee, Z.Y. Wang, H. Li, L. Chen, Y. Sun, S. Gobbo, D.A. Balentine, and C.S. Yang Analysis of plasma and urinary tea polyphenols in human subjects Cancer Epidemiology, Biomarkers and Prevention 4 1995 393 399
86. C.G. Lee, M.M. Gottesman, C.O. Cardarelli, M. Ramachandra, K.T. Jeang, S.V. Ambudkar, I. Pastan, and S. Dey HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter Biochemistry 37 1998 3594 3601
87. Y.J. Lee, H. Kusuhara, J.W. Jonker, A.H. Schinkel, and Y. Sugiyama Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein Journal of Pharmacology and Experimental Therapeutics 312 2005 44 52
88. E.M. Leslie, R.G. Deeley, and S.P. Cole Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters Toxicology 167 2001 3 23
89. E.M. Leslie, Q. Mao, C.J. Oleschuk, R.G. Deeley, and S.P. Cole Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids Molecular Pharmacology 59 2001 1171 1180
90. E.M. Leslie, R.G. Deeley, and S.P. Cole Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1) Drug Metabolism and Disposition 31 2003 11 15
91. C.R. Lincke, J.J. Smit, T. van der Velde-Koerts, and P. Borst Structure of the human MDR3 gene and physical mapping of the human MDR locus Journal of Biological Chemistry 266 1991 5303 5310
92. J. Linseisen, R. Piller, S. Hermann, and J. Chang-Claude Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study International Journal of Cancer 110 2004 284 290
93. A.F. List Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia Leukemia 10 1996 937 942
94. T. Litman, T.E. Druley, W.D. Stein, and S.E. Bates From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance Cellular and Molecular Life Sciences 58 2001 931 959
95. Y. Liu, and M. Hu Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model Drug Metabolism and Disposition 30 2002 370 377
96. D.W. Loe, K.C. Almquist, R.G. Deeley, and S.P. Cole Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport Journal of Biological Chemistry 271 1996 9675 9682
97. D.W. Loe, R.G. Deeley, and S.P. Cole Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione Cancer Research 58 1998 5130 5136
98. A. Lorico, G. Rappa, R.A. Finch, D. Yang, R.A. Flavell, and A.C. Sartorelli Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione Cancer Research 57 1997 5238 5242
99. M. Maliepaard, G.L. Scheffer, I.F. Faneyte, M.A. van Gastelen, A.C. Pijnenborg, A.H. Schinkel, M.J. van De Vijver, R.J. Scheper, and J.H. Schellens Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer Research 61 2001 3458 3464
100. C. Manach, C. Morand, A. Gil-Izquierdo, C. Bouteloup-Demange, and C. Remesy Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice European Journal of Clinical Nutrition 57 2003 235 242
101. J.P. Marie, R. Zittoun, and B.I. Sikic Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity Blood 78 1991 586 592
102. J. Meador, P. Sweet, M. Stupecky, M. Wetzel, S. Murray, S. Gupta, and L. Slater Enhancement by cyclosporin A of daunorubicin efficacy in Ehrlich ascites carcinoma and murine hepatoma 129 Cancer Research 47 1987 6216 6219
103. M.J. Messina, V. Persky, K.D. Setchell, and S. Barnes Soy intake and cancer risk: a review of the in vitro and in vivo data Nutrition and Cancer 21 1994 113 131
104. E. Middleton Jr., C. Kandaswami, and T.C. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacological Reviews 52 2000 673 751
105. D.S. Miller, S.N. Nobmann, H. Gutmann, M. Toeroek, J. Drewe, and G. Fricker Xenobiotic transport across isolated brain microvessels studied by confocal microscopy Molecular Pharmacology 58 2000 1357 1367
106. Y. Mitsunaga, H. Takanaga, H. Matsuo, M. Naito, T. Tsuruo, H. Ohtani, and Y. Sawada Effect of bioflavonoids on vincristine transport across blood-brain barrier European Journal of Pharmacology 395 2000 193 201
107. K. Miyake, L. Mickley, T. Litman, Z. Zhan, R. Robey, B. Cristensen, M. Brangi, L. Greenberger, M. Dean, T. Fojo, and S.E. Bates Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes Cancer Research 59 1999 8 13
108. H. Nguyen, S. Zhang, and M.E. Morris Effect of flavonoids on MRP1-mediated transport in Panc-1 cells Journal of Pharmaceutical Sciences 92 2003 250 257
109. H. Ni, C. Simile, and A.M. Hardy Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey Medical Care 40 2002 353 358
110. S.E. Nielsen, V. Breinholt, U. Justesen, C. Cornett, and L.O. Dragsted In vitro biotransformation of flavonoids by rat liver microsomes Xenobiotica 28 1998 389 401
111. K. Nooter, and P. Sonneveld Clinical relevance of P-glycoprotein expression in haematological malignancies Leukemia Research 18 1994 233 243
112. K. Nooter, G. Brutel de la Riviere, M.P. Look, K.E. van Wingerden, S.C. Henzen-Logmans, R.J. Scheper, M.J. Flens, J.G. Klijn, G. Stoter, and J.A. Foekens The prognostic significance of expression of the multidrug resistance- associated protein (MRP) in primary breast cancer British Journal of Cancer 76 1997 486 493
113. M.D. Norris, D. De Graaf, M. Haber, M. Kavallaris, J. Madafiglio, J. Gilbert, E. Kwan, B.W. Stewart, E.B. Mechetner, A.V. Gudkov, and I.B. Roninson Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate International Journal of Cancer 65 1996 613 619
114. Y. Oshika, M. Nakamura, T. Tokunaga, Y. Fukushima, Y. Abe, Y. Ozeki, H. Yamazaki, N. Tamaoki, and Y. Ueyama Multidrug resistance-associated protein and mutant p53 protein expression in non-small cell lung cancer Modern Pathology 11 1998 1059 1063
115. E. Ota, Y. Abe, Y. Oshika, Y. Ozeki, M. Iwasaki, H. Inoue, H. Yamazaki, Y. Ueyama, K. Takagi, and T. Ogata Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer British Journal of Cancer 72 1995 550 554
116. C.C. Paulusma, M. Kool, P.J. Bosma, G.L. Scheffer, F. ter Borg, R.J. Scheper, G.N. Tytgat, P. Borst, F. Baas, and R.P. Oude Elferink A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome Hepatology 25 1997 1539 1542
117. J.M. Phang, C.M. Poore, J. Lopaczynska, and G.C. Yeh Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells Cancer Research 53 1993 5977 5981
118. H. Potschka, and W. Loscher In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats Epilepsia 42 2001 1231 1240
119. H. Potschka, M. Fedrowitz, and W. Loscher Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity Journal of Pharmacology and Experimental Therapeutics 306 2003 124 131
120. S.M. Potter, J.A. Baum, H. Teng, R.J. Stillman, N.F. Shay, and J.W. Erdman Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women American Journal of Clinical Nutrition 68 1998 1375S 1379S
121. K. Rajnarayana, M.S. Reddy, J. Vidyasagar, and D.R. Krishna Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole Arzneimittelforschung 54 2004 109 113
122. V.V. Rao, J.L. Dahlheimer, M.E. Bardgett, A.Z. Snyder, R.A. Finch, A.C. Sartorelli, and D. Piwnica-Worms Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood- cerebrospinal-fluid drug-permeability barrier Proceedings of the National Academy of Sciences of the United States of America 96 1999 3900 3905
123. K. Reinli, and G. Block Phytoestrogen content of foods-a compendium of literature values Nutrition and Cancer 26 1996 123 148
124. J. Renes, E.G. de Vries, E.F. Nienhuis, P.L. Jansen, and M. Muller ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1 British Journal of Pharmacology 126 1999 681 688
125. L. Rice, V.G. Samedi, T.A. Medrano, C.A. Sweeney, H.V. Baker, A. Stenstrom, J. Furman, and K.T. Shiverick Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts Prostate 52 2002 201 212
126. R.W. Robey, W.Y. Medina-Perez, K. Nishiyama, T. Lahusen, K. Miyake, T. Litman, A.M. Senderowicz, D.D. Ross, and S.E. Bates Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells Clinical Cancer Research 7 2001 145 152
127. D.D. Ross, J.E. Karp, T.T. Chen, and L.A. Doyle Expression of breast cancer resistance protein in blast cells from patients with acute leukemia Blood 96 2000 365 368
128. S.A. Ross, D.S. Ziska, K. Zhao, and M.A. ElSohly Variance of common flavonoids by brand of grapefruit juice Fitoterapia 71 2000 154 161
129. S. Ruetz, and P. Gros Phosphatidylcholine translocase: a physiological role for the mdr2 gene Cell 77 1994 1071 1081
130. J.M. Sargent, C.J. Williamson, M. Maliepaard, A.W. Elgie, R.J. Scheper, and C.G. Taylor Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia British Journal of Haematology 115 2001 257 262
131. A. Sauerbrey, W. Sell, D. Steinbach, A. Voigt, and F. Zintl Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia British Journal of Haematology 118 2002 147 150
132. G. Scambia, F.O. Ranelletti, P.B. Panici, R. De Vincenzo, G. Bonanno, G. Ferrandina, M. Piantelli, S. Bussa, C. Rumi, and M. Cianfriglia Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target Cancer Chemotherapy and Pharmacology 34 1994 459 464
133. T.P. Schaub, J. Kartenbeck, J. Konig, H. Spring, J. Dorsam, G. Staehler, S. Storkel, W.F. Thon, and D. Keppler Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma Journal of the American Society of Nephrology 10 1999 1159 1169
134. J.H. Schellens, M. Maliepaard, R.J. Scheper, G.L. Scheffer, J.W. Jonker, J.W. Smit, J.H. Beijnen, and A.H. Schinkel Transport of topoisomerase I inhibitors by the breast cancer resistance protein. Potential clinical implications Annals of the New York Academy of Sciences 922 2000 188 194
135. A.H. Schinkel, J.J. Smit, O. van Tellingen, J.H. Beijnen, E. Wagenaar, L. van Deemter, C.A. Mol, M.A. van der Valk, E.C. Robanus-Maandag, and H.P. te Riele Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs Cell 77 1994 491 502
136. A.H. Schinkel, E. Wagenaar, L. van Deemter, C.A. Mol, and P. Borst Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A Journal of Clinical Investigation 96 1995 1698 1705
137. A.H. Schinkel, U. Mayer, E. Wagenaar, C.A. Mol, L. van Deemter, J.J. Smit, M.A. van der Valk, A.C. Voordouw, H. Spits, and O. van Tellingen Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins Proceedings of the National Academy of Sciences of the United States of America 94 1997 4028 4033
138. K.D. Setchell, N.M. Brown, P. Desai, L. Zimmer-Nechemias, B.E. Wolfe, W.T. Brashear, A.S. Kirschner, A. Cassidy, and J.E. Heubi Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements Journal of Nutrition 131 2001 1362S 1375S
139. A.B. Shapiro, and V. Ling Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein Biochemical Pharmacoogyl 53 1997 587 596
140. A.B. Shapiro, and V. Ling Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities European Journal of Biochemistry 250 1997 130 137
141. P. Siegenthaler, S.B. Kaye, S. Monfardini, and J. Renard Phase II trial with Flavone Acetic Acid (NSC.347512, LM975) in patients with non-small cell lung cancer Annals of Oncology 3 1992 169 170
142. J.J. Smit, A.H. Schinkel, R.P. Oude Elferink, A.K. Groen, E. Wagenaar, L. van Deemter, C.A. Mol, R. Ottenhoff, N.M. van der Lugt, and M.A. van Roon Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease Cell 75 1993 451 462
143. J.J. Smit, A.H. Schinkel, C.A. Mol, D. Majoor, W.J. Mooi, A.P. Jongsma, C.R. Lincke, and P. Borst Tissue distribution of the human MDR3 P-glycoprotein Laboratory Investigation 71 1994 638 649
144. A.J. Smith, J.L. Timmermans-Hereijgers, B. Roelofsen, K.W. Wirtz, W.J. van Blitterswijk, J.J. Smit, A.H. Schinkel, and P. Borst The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice FEBS Letters 354 1994 263 266
145. A. Sparreboom, J. van Asperen, U. Mayer, A.H. Schinkel, J.W. Smit, D.K. Meijer, P. Borst, W.J. Nooijen, J.H. Beijnen, and O. van Tellingen Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by
146. D. Steinbach, W. Sell, A. Voigt, J. Hermann, F. Zintl, and A. Sauerbrey BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia Leukemia 16 2002 1443 1447
147. I. Sugawara, H. Yamada, H. Nakamura, T. Sumizawa, S. Akiyama, A. Masunaga, and S. Itoyama Preferential expression of the multidrug-resistance- associated protein (MRP) in adenocarcinoma of the lung International Journal of Cancer 64 1995 322 325
148. M. Suzuki, H. Suzuki, Y. Sugimoto, and Y. Sugiyama ABCG2 transports sulfated conjugates of steroids and xenobiotics Journal of Biological Chemistry 278 2003 22644 22649
149. Y. Tada, M. Wada, T. Migita, J. Nagayama, E. Hinoshita, Y. Mochida, Y. Maehara, M. Tsuneyoshi, M. Kuwano, and S. Naito Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin International Journal of Cancer 98 2002 630 635
150. J. Taipalensuu, H. Tornblom, G. Lindberg, C. Einarsson, F. Sjoqvist, H. Melhus, P. Garberg, B. Sjostrom, B. Lundgren, and P. Artursson Correlation of gene expression of ten drug efflux proteins of the ATP- binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers Journal of Pharmacology and Experimental Therapeutics 299 2001 164 170
151. F. Thiebaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan, and M.C. Willingham Cellular localization of the multidrug-resistance gene product P- glycoprotein in normal human tissues Proceedings of the National Academy of Sciences of the United States of America 84 1987 7735 7738
152. F. Thiebaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan, and M.C. Willingham Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein Journal of Histochemistry and Cytochemistry 37 1989 159 164
153. S. Toh, M. Wada, T. Uchiumi, A. Inokuchi, Y. Makino, Y. Horie, Y. Adachi, S. Sakisaka, and M. Kuwano Genomic structure of the canalicular multispecific organic anion- transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome American Journal of Human Genetics 64 1999 739 746
154. D. Trompier, H. Baubichon-Cortay, X.B. Chang, M. Maitrejean, D. Barron, J.R. Riordon, and A. Di Pietro Multiple flavonoid-binding sites within multidrug resistance protein MRP1 Cellular and Molecular Life Sciences 60 2003 2164 2177
155. T. Tsuruo, H. Iida, Y. Kitatani, K. Yokota, S. Tsukagoshi, and Y. Sakurai Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells Cancer Research 44 1984 4303 4307
156. K. Ueda, N. Okamura, M. Hirai, Y. Tanigawara, T. Saeki, N. Kioka, T. Komano, and R. Hori Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone Journal of Biological Chemistry 267 1992 24248 24252
157. J.B. Vaidyanathan, and T. Walle Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2 Pharmaceutical Research 18 2001 1420 1425
158. J.B. Vaidyanathan, and T. Walle Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2 Journal of Pharmacology and Experimental Therapeutics 307 2003 745 752
159. D.M. van der Kolk, E. Vellenga, G.L. Scheffer, M. Muller, S.E. Bates, R.J. Scheper, and E.G. de Vries Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia Blood 99 2002 3763 3770
160. A.G. van der Zee, H. Hollema, A.J. Suurmeijer, M. Krans, W.J. Sluiter, P.H. Willemse, J.G. Aalders, and E.G. de Vries Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas Journal of Clinical Oncology 13 1995 70 78
161. C.K. van Kalken, H.J. Broxterman, H.M. Pinedo, N. Feller, H. Dekker, J. Lankelma, and G. Giaccone Cortisol is transported by the multidrug resistance gene product P- glycoprotein British Journal of Cancer 67 1993 284 289
162. J.J. van Zanden, L. Geraets, H.M. Wortelboer, P.J. van Bladeren, I.M. Rietjens, and N.H. Cnubben Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells Biochemical Pharmacology 67 2004 1607 1617
163. J.J. van Zanden, H.M. Wortelboer, S. Bijlsma, A. Punt, M. Usta, P.J. Bladeren, I.M. Rietjens, and N.H. Cnubben Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2 Biochemical Pharmacology 69 2005 699 708
164. C.H. Versantvoort, G.J. Schuurhuis, H.M. Pinedo, C.A. Eekman, C.M. Kuiper, J. Lankelma, and H.J. Broxterman Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells British Journal of Cancer 68 1993 939 946
165. C.H. Versantvoort, H.J. Broxterman, J. Lankelma, N. Feller, and H.M. Pinedo Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells Biochemical Pharmacology 48 1994 1129 1136
166. E.L. Volk, K.M. Farley, Y. Wu, F. Li, R.W. Robey, and E. Schneider Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance Cancer Research 62 2002 5035 5040
167. R.A. Walgren, K.J. Karnaky Jr., G.E. Lindenmayer, and T. Walle Efflux of dietary flavonoid quercetin 4′-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2 Journal of Pharmacology and Experimental Therapeutics 294 2000 830 836
168. R.A. Walgren, J.T. Lin, R.K. Kinne, and T. Walle Cellular uptake of dietary flavonoid quercetin 4′-beta-glucoside by sodium-dependent glucose transporter SGLT1 Journal of Pharmacology and Experimental Therapeutics 294 2000 837 843
169. T. Walle, and U.K. Walle The beta-D-glucoside and sodium-dependent glucose transporter 1 (SGLT1)-inhibitor phloridzin is transported by both SGLT1 and multidrug resistance-associated proteins 1/2 Drug Metabolism and Disposition 31 2003 1288 1291
170. U.K. Walle, K.L. French, R.A. Walgren, and T. Walle Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2 Research Communications in Molecular Pathology and Pharmacology 103 1999 45 56
171. U.K. Walle, A. Galijatovic, and T. Walle Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2 Biochemical Pharmacology 58 1999 431 438
172. T. Walle, Y. Otake, U.K. Walle, and F.A. Wilson Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption Journal of Nutrition 130 2000 2658 2661
173. T. Walle, Y. Otake, J.A. Brubaker, U.K. Walle, and P.V. Halushka Disposition and metabolism of the flavonoid chrysin in normal volunteers British Journal of Clinical Pharmacology 51 2001 143 146
174. X. Wang, T. Furukawa, T. Nitanda, M. Okamoto, Y. Sugimoto, S. Akiyama, and M. Baba Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors Molecular Pharmacology 63 2003 65 72
175. Y.H. Wang, P.D. Chao, S.L. Hsiu, K.C. Wen, and Y.C. Hou Lethal quercetin-digoxin interaction in pigs Life Sciences 74 2004 1191 1197
176. J. Wijnholds, R. Evers, M.R. van Leusden, C.A. Mol, G.J. Zaman, U. Mayer, J.H. Beijnen, M. van der Valk, P. Krimpenfor, and P. Borst Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein Nature Medicine 3 1997 1275 1279
177. J. Wijnholds, E.C. deLange, G.L. Scheffer, D.J. van den Berg, C.A. Mol, M. van der Valk, A.H. Schinkel, R.J. Scheper, D.D. Breimer, and P. Borst Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier Journal of Clinical Investigation 105 2000 279 285
178. S. Wolffram, M. Block, and P. Ader Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine Journal of Nutrition 132 2002 630 635
179. M. Yoshikawa, Y. Ikegami, K. Sano, H. Yoshida, H. Mitomo, S. Sawada, and T. Ishikawa Transport of SN-38 by the wild type of human ABC transporter ABCG2 and its inhibition by quercetin, a natural flavonoid Journal of Experimental Therapy and Oncology 4 2004 25 35
180. L.C. Young, B.G. Campling, T. Voskoglou-Nomikos, S.P. Cole, R.G. Deeley, and J.H. Gerlach Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response Clinical Cancer Research 5 1999 673 680
181. G.J. Zaman, M.J. Flens, M.R. van Leusden, M. de Haas, H.S. Mulder, J. Lankelma, H.M. Pinedo, R.J. Scheper, F. Baas, and H.J. Broxterman The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump Proceedngs of the National Academy of Science of the United States of America 91 1994 8822 8826
182. S. Zhang, and M.E. Morris Effects of the flavonoids biochanin A, morin, phloretin and silymarin on P-glycoprotein-mediated transport Journal of Experimental Pharmacology and Therapeutics 304 2003 1258 1267
183. H. Zhang, C.W. Wong, P.F. Coville, and S. Wanwimolruk Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats Drug Metabolism and Drug Interactons 17 2000 351 363
184. W. Zhang, J. Mojsilovic-Petrovic, M.F. Andrade, H. Zhang, M. Ball, and D.B. Stanimirovic Expression and functional characterization of ABCG2 in brain endothelial cells and vessels FASEB Journal 17 2003 2085 2087
185. S. Zhang, X. Yang, and M.E. Morris Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport Pharmaceutical Research 21 2004 1263 1273
186. S. Zhang, X. Yang, and M.E. Morris Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport Molecular Pharmacology 65 2004 1208 1216
187. S. Zhang, X. Yang, R.A. Coburn, and M.E. Morris Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein Biochem Pharmacol 70 2005 627 639
188. S. Zhang, X. Wang, K. Sagawa, and M.E. Morris Flavonoids chrysin and benzoflavone, potent breast cancer resistance protein inhibitors, have no significant effect on topotecan pharmacokinetics in rats or mdr1a/1b (-/-) mice Drug Metabolism and Disposition 33 2005 341 348
189. S. Zochbauer, A. Gsur, R. Brunner, P.A. Kyrle, K. Lechner, and R. Pirker P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia Leukemia 8 1994 974 977